Li-Chia Chen
Lecturer, Faculty of Science
Contact
Biography
I am a Taiwanese pharmacist registered in 1993 and worked as a hospital pharmacist. From 1995, I did a MSc course at the Institute of Clinical Pharmacy, Cheng-Kung University, majoring in drug utilisation evaluation and pharmacoepidemiology. From 1996 to 1998, I was a Teaching Assistant at the Institute and a Clinical Pharmacist at the University Hospital, specialising in infectious diseases.
Between 1999 and 2001, I was a Director of Pharmacy in a local hospital and a university Lecturer in southern Taiwan. Being sponsored by the Taiwanese Ministry of Education, I started my PhD programme at the Drug Usage and Pharmacy Practice Group in the School of Pharmacy and Pharmaceutical Sciences at the University of Manchester in 2001, for a clinical outcome and cost-effectiveness research. I worked as a Research Associate for health economic teaching and meta-analysis research in the Group after granted PhD in 2005.
From 2007 to March 2010, I worked as an Assistant Professor at the Graduate Institute of Clinical Pharmacy, Kaohsiung Medical University in Taiwan. I heavily involved in teaching and outcome and economic research on clinical and policy-related health care issues. In April 2010, I moved to Nottingham and worked as a Lecturer in Medicine Use.
Research Summary
My main research interest is to assess the clinical and economic impacts of treatments or health-care policy. My current research and international collaborations are as following:
- Principle investigator of project funded by University of Nottingham: Evaluating the utilisation and clinical impacts of generic substitution policy- a preliminary research on angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for treating hypertension [Early Career Research and Knowledge Transfer 2011, on process]
- Co-investigator of international research projects: Acupuncture or physical therapy?- Low-back pain patients' choice [Research Committee University of Macau, 230,000 MOP, Jan 2010-Jan 2012]Pharmcoeconomic modelling of type 2 diabetes mellitus: A computer simulation of lifetime costs and clinical outcomes [Research Committee University of Macau, 70,2000 MOP, Jan 2011-Jan 2014] Evaluation on a hospital clinical pathway for managing acute Herpes Zoster in China [Research Committee University of Macau, on processing]
- Supervisor of Taiwanese M.C.Pharm and Ph.D. projects: Effectiveness and quality of life associated with the diabetic pay-for-performance program in Taiwan- M.C.Pharm. project Cost-of-illness analysis of irritable bowel syndrome in Taiwan- M.C.Pharm. project Clinical and cost-effectiveness of anti-hepatitis B treatment in Taiwan- M.C.Pharm. & Ph.D. project Clinical and cost-Effectiveness of imatinib versus stem cell transplantation in the treatment of chronic myeloid leukaemia in Taiwan- M.C.Pharm. & Ph.D. project
Recent Publications
SHABARUDDIN FH, CHEN LC, ELLIOTT RA and PAYNE K, 2012. Quantifying the impact of chemotherapy-related adverse events for economic evaluations PharmacoEconomics. (In Press.)
CHEN H-Y and CHEN L-C, 2010. The implementation of innovative pharmacogenetic test into practice in Taiwan: An institutional perspective Drug Development Research. 71, 502-506
CHEN L-C, SCHAFHEUTLE EI and NOYCE PR, 2009. The impact of nonreferral outpatient co-payment on medical care utilization and expenditure in Taiwan Research in Social and Administrative Pharmacy. 5(3), 211-224 CHEN L-C and ASHCROFT DM, 2008. Meta-analysis of the efficacy and safety of zolmitriptan in the acute treatment of migraine. Headache. 48(2), 236-47